about
Acadesine for patients with relapsed/refractory chronic lymphocytic leukemia (CLL): a multicenter phase I/II studyAntilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease.Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab.Analysis of economic and social costs of adverse events associated with blood transfusions in Spain.Sequential vs alternating administration of VMP and Rd in elderly patients with newly diagnosed MMPhase I Study of TAK-659, an Investigational, Dual SYK/FLT3 Inhibitor, in Patients with B-cell Lymphoma
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Jaime Pérez de Oteyza
@en
Jaime Pérez de Oteyza
@nl
type
label
Jaime Pérez de Oteyza
@en
Jaime Pérez de Oteyza
@nl
prefLabel
Jaime Pérez de Oteyza
@en
Jaime Pérez de Oteyza
@nl
P31
P496
0000-0002-8338-2037